enGene Holdings Inc.
ENGN$154M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSAINT-LAURENT
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ENGN News
Catalyst Timeline
1 upcoming, 2 past
Phase 2Next
~MixedEG-70 (phase 1) Phase 2 Est. Readout
June 2026~ConfirmedEG-70 (phase 1)350
Primary completion for EG-70 (phase 1) trial (NCT04752722) in Superficial Bladder Cancer
Phase 2 durability data released
SourceDrug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EG-70 (phase 1) | Phase 2 | Superficial Bladder Cancer | - | - |
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply